Stock 4548 SEIKAGAKU CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Funds and ETFs Seikagaku Corporation

Equities

4548

JP3414000004

Pharmaceuticals

Market Closed - Japan Exchange
Other stock markets
 07:00:00 21/06/2024 BST 		5-day change 1st Jan Change
876 JPY +1.51% Intraday chart for Seikagaku Corporation +5.67% +15.11%
04-08 Ferring Pharmaceuticals Inc. Presents Pivotal Phase 3 Efficacy and Safety Data for Investigational Treatment, SI-6603, in Lumbar Disc Herniation at ASIPP 2024 CI
2023 Seikagaku Corporation Reports Earnings Results for the Full Year Ended March 31, 2023 CI

ETFs positioned on Seikagaku Corporation

Name Weight AuM 1st Jan change Investor Rating
NOMURA NEXT FUNDS TOPIX-17 PHARMACEUTICAL ETF - JPY ETF Nomura NEXT FUNDS TOPIX-17 PHARMACEUTICAL ETF - JPY
0.09% 14 M€ +9.47%
NZAM ETF TOPIX EX-FINANCIALS - JPY ETF NZAM ETF TOPIX Ex-Financials - JPY
0.01% 17 M€ +18.02% -
NOMURA TOPIX EXCHANGE TRADED FUND ETF - JPY ETF Nomura TOPIX Exchange Traded Fund ETF - JPY
0.01% 138,841 M€ +16.37%
MAXIS TOPIX ETF - JPY ETF MAXIS TOPIX ETF - JPY
0.01% 19,753 M€ +15.18% -

Company Profile

SEIKAGAKU CORPORATION is principally engaged in the research, development, purchase, manufacture and sale of pharmaceutical products and limulus amebocyte lysate (LAL). The Company operates in two business segments. The Pharmaceutical business segment provides hyaluronan-based medicines for joint function improvement, ophthalmic operation boosters and submucosal injection materials for endoscopes, as well as drug substances for various pharmaceuticals. The LAL business segment provides reagents for measuring endotoxin.
Sector
Pharmaceuticals
Calendar
01/08/2024 - Q1 2024 Earnings Release (Projected)
More about the company

Income Statement Evolution

More financial data

Ratings for Seikagaku Corporation

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
SEIKAGAKU CORPORATION Stock Seikagaku Corporation
+15.11% 300M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+51.63% 796B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+41.51% 628B
JOHNSON & JOHNSON Stock Johnson & Johnson
-5.10% 358B
MERCK & CO., INC. Stock Merck & Co., Inc.
+19.90% 331B
ABBVIE INC. Stock AbbVie Inc.
+9.95% 301B
ASTRAZENECA PLC Stock AstraZeneca PLC
+17.66% 244B
ROCHE HOLDING AG Stock Roche Holding AG
+3.39% 228B
NOVARTIS AG Stock Novartis AG
+10.75% 214B
AMGEN INC. Stock Amgen Inc.
+6.99% 165B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 4548 Stock
  4. Funds and ETFs Seikagaku Corporation